| Autor: |
Hyung-Don Kim, Seyoung Jung, Ho Yeong Lim, Baek-Yeol Ryoo, Min-Hee Ryu, Hong Jae Chon, Beodeul Kang, Jung Yong Hong, Han Chu Lee, Deok-Bog Moon, Ki-Hoon Kim, Tae Won Kim, Jeong Seok Lee, Richard S. Finn, June-Young Koh, Changhoon Yoo |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| DOI: |
10.5281/zenodo.8131764 |
| Popis: |
Regorafenib plus nivolumab (RegoNivo) combination has shown promising anti-cancer activity in multiple cancer types. REBNOBATE trial is a single-arm multicenter phase 2 trial of first-line RegoNivo in patients (pts) with uHCC (NCT04310709). Here we report the clinical outcomes of the RENOBATE study and integrative biomarker analysis using circulating tumor DNA (ctDNA) and single cell RNA sequencing (scRNA-seq) analysis. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
